Log in

NASDAQ:AGLEAeglea Bio Therapeutics Earnings Date, Estimates & History

+0.09 (+0.99 %)
(As of 07/9/2020 04:00 PM ET)
Today's Range
Now: $9.19
50-Day Range
MA: $9.09
52-Week Range
Now: $9.19
Volume202,100 shs
Average Volume461,577 shs
Market Capitalization$409.87 million
P/E RatioN/A
Dividend YieldN/A


Aeglea Bio Therapeutics (NASDAQ:AGLE) Earnings Information

Aeglea Bio Therapeutics last announced its earnings data on May 7th, 2020. The biotechnology company reported ($0.57) EPS for the quarter, topping analysts' consensus estimates of ($0.65) by $0.08. Aeglea Bio Therapeutics has generated ($2.45) earnings per share over the last year. Aeglea Bio Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 4th, 2020 based off prior year's report dates.

Aeglea Bio Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Aeglea Bio Therapeutics (NASDAQ:AGLE) Earnings Estimates

2020 EPS Consensus Estimate: ($1.73)
2021 EPS Consensus Estimate: ($1.62)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20201($0.62)($0.62)($0.62)
Q2 20201($0.41)($0.41)($0.41)
Q3 20201($0.34)($0.34)($0.34)
Q4 20201($0.36)($0.36)($0.36)
Q1 20211($0.37)($0.37)($0.37)
Q2 20211($0.40)($0.40)($0.40)
Q3 20211($0.41)($0.41)($0.41)
Q4 20211($0.44)($0.44)($0.44)

Aeglea Bio Therapeutics (NASDAQ AGLE) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
2/24/2020Q4 2019($0.6680)($0.6503)($0.65)N/A
8/6/2019Q2 2019($0.4820)($0.55)($0.55)N/A
8/9/2018Q2 2018($0.3640)($0.46)($0.46)$2.38 millionN/A
5/8/2018Q1 2018($0.4430)($0.49)($0.49)$1.51 millionN/A
3/13/2018Q4 2017($0.38)($0.38)$1.48 millionN/A
11/7/2017Q3 2017($0.55)($0.48)($0.48)$1.26 millionN/A
8/9/2017Q2 2017($0.59)($0.47)($0.47)$1.48 millionN/A
5/9/20173/31/2017($0.47)($0.47)($0.47)$0.98 millionN/A
3/23/2017Q4 2016($0.41)($0.41)$1.25 millionN/A
11/9/20169/30/2016($0.54)($0.47)($0.47)$1.15 millionN/A
8/9/2016Q2 2016($0.43)($0.46)($0.46)$1.37 millionN/A
5/19/2016Q1 2016($0.42)($7.10)($7.10)$0.86 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 7/10/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.